OnKure Therapeutics (OKUR)

• Market cap: $63.9M
• 1 day: 3.55%
• 5 days: 8.86%
• 1 month: 19.74%
• 3 months: 55.67%
• 6 months: 62.15%
• Year to date: 57.77%
• 1 year: 59.39%
• 5 years: -96.41%
• 10 years: -96.64%
• Sector: Healthcare
• Industry: Biotechnology

About: OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.

Employees: 45